A randomized, multicenter trial to evaluate the safety and immunogenicity of staphylococcus aureus toxoids, RAT and rluks-PV, in healthy volunteers
Ended Cooperative Agreement Awarded
- Award ID
- W81XWH0920151
- Recipient
-
Nabi Biopharmaceuticals UEI DK92BKNVVVB9
- Awarding agency
-
Department of the Army
Department of Defense
- Obligated
- $471,917
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Funding agency
- Department of Defense
- Place of performance
- Highland Beach, FL 33487, USA
Award details come from USAspending.gov.
Quick answers
Who received award W81XWH0920151?
W81XWH0920151 was awarded to Nabi Biopharmaceuticals by Department of the Army (Department of Defense) on September 21, 2009.
How much is award W81XWH0920151 worth?
$471,917 has been obligated on W81XWH0920151.
Which agency awarded W81XWH0920151?
Department of the Army (Department of Defense) awarded W81XWH0920151, with funding from Department of Defense.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award